Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Diabetes Association
Biotech
Lilly's next obesity drug just cut an average of 58 pounds
Fifty-eight pounds. That’s how much weight patients lost on average at the end of 48 weeks when taking Eli Lilly’s next-generation obesity treatment.
Annalee Armstrong
Jun 26, 2023 8:45pm
Boehringer shares more ph. 2 obesity data for Lilly, Novo rival
Jun 23, 2023 5:15pm
ADA: TB vaccine restores key immune cells in Type 1 diabetes
Jun 28, 2021 10:35am
ADA: Insulet's new Omnipod shows gains in preschoolers with T1D
Jun 28, 2021 9:20am
ADA: Insulet delivers first data for its wearable insulin pump
Jun 16, 2020 3:45pm
ADA: Onduo's virtual clinic helps lower A1c in diabetes studies
Jun 16, 2020 1:00pm